129 related articles for article (PubMed ID: 8370105)
1. Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives containing nitrooxyalkylester moieties at the 3- and 5-positions.
Ogawa T; Nakazato A; Tsuchida K; Hatayama K
Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1049-54. PubMed ID: 8370105
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity study of antihypertensive 1,4-dihydropyridine derivatives having nitrooxyalkyl moieties at the 3 and 5 positions.
Kawashima Y; Ogawa T; Kato M; Nakazato A; Tsuchida K; Hatayama K; Hirono S; Moriguchi I
Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1060-5. PubMed ID: 8370106
[TBL] [Abstract][Full Text] [Related]
3. The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities.
Liang JC; Yeh JL; Wang CS; Liou SF; Tsai CH; Chen IJ
Bioorg Med Chem; 2002 Mar; 10(3):719-30. PubMed ID: 11814861
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives containing a nitrooxy moiety at the 3-ester position.
Ogawa T; Nakazato A; Tsuchida K; Hatayama K
Chem Pharm Bull (Tokyo); 1993 Jan; 41(1):108-16. PubMed ID: 8448812
[TBL] [Abstract][Full Text] [Related]
5. Novel 2-amino-1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having N,N-dialkylaminoalkoxycarbonyl groups at 3- and/or 5-position.
Kobayashi T; Inoue T; Nishino S; Fujihara Y; Oizumi K; Kimura T
Chem Pharm Bull (Tokyo); 1995 May; 43(5):797-817. PubMed ID: 7553967
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of antihypertensive agents via coupling reaction of benzothiazepinone and 1,4-dihydropyridine derivatives.
Ham WH; Yang JG; Lim TG; Jung YH; Chung YS
Arch Pharm Res; 1994 Apr; 17(2):119-23. PubMed ID: 10319143
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antihypertensive activity of 1,4-dihydropyridine derivatives with a 4-(disubstituted phenyl) ring and an aminoalkyl ester group: highly potent and long-lasting calcium antagonists.
Kanno H; Yamaguchi H; Okamiya Y; Sunakawa K; Takeshita T; Naruchi T
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2049-54. PubMed ID: 1423758
[TBL] [Abstract][Full Text] [Related]
8. Novel 1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive activity of 3-[4-(substituted amino)phenylalkyl]ester derivatives.
Ashimori A; Ono T; Inoue Y; Morimoto S; Eda M; Uchida T; Ohtaki Y; Fujino Y; Kido H; Ogura Y
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):91-9. PubMed ID: 2049813
[TBL] [Abstract][Full Text] [Related]
9. Novel 2-amino-1,4-dihydropyridine calcium antagonists. I. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having nitroxy-alkoxycarbonyl groups at 3- and/or 5-position.
Kobayashi T; Inoue T; Kita Z; Yoshiya H; Nishino S; Oizumi K; Kimura T
Chem Pharm Bull (Tokyo); 1995 May; 43(5):788-96. PubMed ID: 7553966
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antihypertensive activities of new 1,4-dihydropyridine containing nitroimidazolyl substituent with a nitrooxy group at the 3-ester position.
Shafiee A; Rastkary N; Jorjani M; Shafaghi B
Arch Pharm (Weinheim); 2002 Mar; 335(2-3):69-76. PubMed ID: 12043457
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
Kanda A; Haruno A; Miyake H; Nagasaka M
J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive and antiarrhythmic properties of a para-hydroxy[bis(ortho-morpholinylmethyl)]phenyl-1,4-DHP compound: comparison with other compounds of the same kind and relationship with logP values.
Abrego VH; Martínez-Pérez B; Torres LA; Angeles E; Martínez L; Marroquín-Pascual JL; Moya-Hernández R; Amaro-Recillas HA; Rueda-Jackson JC; Rodríguez-Barrientos D; Rojas-Hernández A
Eur J Med Chem; 2010 Oct; 45(10):4622-30. PubMed ID: 20705371
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive effect of the new dihydropyridine calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5-nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedica rbo xylate hydrochloride in dogs.
Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
Arzneimittelforschung; 1992 Apr; 42(4):513-8. PubMed ID: 1642675
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological effects of optically active 2-[4-(4-benzhydryl-1-piperazinyl)phenyl]-ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate hydrochloride.
Ashimori A; Uchida T; Ohtaki Y; Tanaka M; Ohe K; Fukaya C; Watanabe M; Kagitani M; Yokoyama K
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):108-11. PubMed ID: 2049794
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 1,4-dihydropyridine-5-phosphonates and their calcium-antagonistic and antihypertensive activities: novel calcium-antagonist 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate hydrochloride ethanol (NZ-105) and its crystal structure.
Sakoda R; Kamikawaji Y; Seto K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2362-9. PubMed ID: 1446356
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel 2-chloro-1,4-dihydropyridines by chlorination of 2-hydroxy-1,4-dihydropyridines with phosphorus oxychloride.
Cho H; Ueda M; Mizuno A; Ishihara T; Aisaka K; Noguchi T
Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2117-21. PubMed ID: 2598311
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activities of optical isomers of 2-(4-diphenylmethyl-1-piperazinyl)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate (manidipine) dihydrochloride.
Kajino M; Wada Y; Nagai Y; Nagaoka A; Meguro K
Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2225-8. PubMed ID: 2598325
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effect of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride in rats.
Wada K; Nakamura S; Morishita S; Kanda M; Matsui H; Fukata F; Shirahase H
Arzneimittelforschung; 1994 Oct; 44(10):1112-6. PubMed ID: 7818582
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive effects of a new dihydropyridine calcium antagonist.
Kimura Y; Fukui H; Tanaka M; Okamoto M; Morino A; Miura A; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1329-35. PubMed ID: 3790182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
